Key Record Dates
ClinicalTrials.gov Identifier: | NCT02335424 |
---|---|
Brief Title: | Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052) |
First Submitted : | January 7, 2015 |
First Submitted that Met QC Criteria : | January 8, 2015 |
First Posted : | January 9, 2015 (Estimate) |
Results First Submitted : | May 29, 2019 |
Results First Submitted that Met QC Criteria : | June 26, 2019 |
Results First Posted : | July 5, 2019 |
Last Update Submitted that Met QC Criteria : | February 2, 2023 |
Last Update Posted : | March 2, 2023 |